CLINICAL_TRIALS
trial_result
· 2023-07-25
Clinical Trial Update: Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 [Phase 3]
Summary
Phase 3 trial evaluating enoxaparin at prophylactic or therapeutic doses in COVID-19 patients; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ASST Fatebenefratelli Sacco | Conditions: Covid19, Thrombosis | Phase 3 | Status: COMPLETED